Skip to main content
DNA Labs India

ITGB4 Gene Epidermolysis bullosa junctionalis with pyloric atresia NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

ITGB4 Gene Epidermolysis bullosa junctionalis with pyloric atresia NGS Genetic Test

Short Name: ITGB4 Gene EB-PA NGS Test

Also known as: ITGB4 Gene Sequencing Test, Junctional Epidermolysis Bullosa Genetic Test, EB-PA NGS Genetic Test, ITGB4 Mutation Analysis, Integrin Beta-4 Gene Test

ITGB4 Gene Epidermolysis bullosa junctionalis with pyloric atresia NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS), Sanger Confirmation of Variants, Bioinformatic Analysis and Variant Calling on Blood or Extracted DNA or One Drop Blood on FTA Card samples. Results in Results are typically available within 3 to 4 weeks from sample receipt at the laboratory. Results can be accessed through the DNA Labs India online portal, sent via email, or delivered via WhatsApp.. Free home collection in 300+ cities across India.

Next-Generation Sequencing (NGS) Genetic TestAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to identify pathogenic or likely pathogenic mutations in the ITGB4 gene responsible for epidermolysis bullosa junctionalis with pyloric atresia. This test aids in confirming a clinical diagnosis, differentiating EB-PA from other subtypes of epidermolysis bullosa, guiding treatment and surgical decisions, enabling carrier detection in family members, facilitating informed genetic counselling for recurrence risk assessment, and supporting prenatal or preconception genetic planning.

Test Code
2401
CPT Code
81479
ICD Code
Q81.2
Price
₹20,000
Sample Type
Blood or Extracted DNA or One Drop Blood on FTA Card
Result Time
Results are typically available within 3 to 4 weeks from sample receipt at the laboratory. Results can be accessed through the DNA Labs India online portal, sent via email, or delivered via WhatsApp.
Fasting Required
No
Method
Next-Generation Sequencing (NGS), Sanger Confirmation of Variants, Bioinformatic Analysis and Variant Calling
Step 1

Sample Collection

A genetic counselling session is recommended prior to testing to document the clinical history of the patient and to draw a pedigree chart of family members affected with epidermolysis bullosa. No fasting is required. Inform the laboratory of any recent blood transfusions. Ensure the referring clinician provides a complete clinical summary including onset, severity, and distribution of blistering, and any gastrointestinal symptoms.

Method: Venipuncture or FTA Card Finger Prick

Step 2

Laboratory Analysis

A trained phlebotomist will collect 3-5 mL of venous blood in an EDTA (lavender top) tube under aseptic conditions. Alternatively, a single drop of blood may be spotted on an FTA card. For extracted DNA samples, ensure the DNA is shipped on dry ice with appropriate documentation. Home sample collection is available across India at no additional charge.

Step 3

Report Delivery

Label the sample correctly with the patient's details. Store at ambient room temperature if using an FTA card or ship the EDTA blood sample within 24 hours of collection at 2-8°C. Do not freeze whole blood samples. Results will be available within 3 to 4 weeks through the online portal, email, or WhatsApp.

Timeline: Results are typically available within 3 to 4 weeks from sample receipt at the laboratory. Results can be accessed through the DNA Labs India online portal, sent via email, or delivered via WhatsApp.

Patient Instructions

1
Before the Test:Schedule a genetic counselling session prior to testing. Provide a detailed clinical history of the patient, including onset and severity of blistering, gastrointestinal symptoms, feeding difficulties, and any prior diagnostic investigations. Draw a pedigree chart documenting family members affected with epidermolysis bullosa or related conditions. No fasting or special preparation is required for blood collection.
2
During the Test:A small blood sample (3-5 mL) will be drawn from a vein in the arm using standard venipuncture. The procedure takes approximately 5-10 minutes. For infants, a heel prick may be used to collect a small blood spot on an FTA card. Mild discomfort or bruising at the puncture site is possible but uncommon.
3
After the Test:After blood collection, apply gentle pressure to the puncture site with a cotton ball or gauze for a few minutes. A small bruise may develop at the site, which typically resolves within a few days. Results will be available within 3 to 4 weeks. Your genetic counsellor or referring physician will contact you to discuss the findings and next steps.

About This Test

Who Should Get This Test

The purpose of this test is to identify pathogenic or likely pathogenic mutations in the ITGB4 gene responsible for epidermolysis bullosa junctionalis with pyloric atresia. This test aids in confirming a clinical diagnosis, differentiating EB-PA from other subtypes of epidermolysis bullosa, guiding treatment and surgical decisions, enabling carrier detection in family members, facilitating informed genetic counselling for recurrence risk assessment, and supporting prenatal or preconception genetic planning.

How to Prepare

  • Collect 3-5 mL venous blood in an EDTA (lavender top) tube under aseptic technique
  • Alternatively, spot one drop of blood on an FTA card and allow it to dry completely
  • For extracted DNA, provide a minimum of 1-2 µg of DNA at a concentration of 50 ng/µL or higher
  • Label the sample with full patient name, date of birth, and unique sample ID
  • Store EDTA blood at 2-8°C and transport within 24 hours of collection
  • Do not freeze whole blood samples
  • Ship extracted DNA on dry ice with an ice pack

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Epidermolysis bullosa junctionalis with pyloric atresia is a severe, often life-threatening condition that presents at birth. Early genetic confirmation through ITGB4 gene testing is critical for guiding surgical management of pyloric atresia, planning long-term dermatological care, and offering accurate genetic counselling to families. I recommend this NGS test for any newborn presenting with widespread blistering and gastrointestinal obstruction when junctional EB is suspected."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One Drop Blood on FTA Card
Sample Volume3-5 mL EDTA Whole Blood or 1-2 µg Extracted DNA
ContainerEDTA (Lavender Top) Tube or FTA Card
Collection MethodVenipuncture or FTA Card Finger Prick

Sample Stability

Sample Rejection Criteria:
  • Sample received without proper patient identification or labelling
  • Haemolysed, clotted, or insufficient volume of EDTA blood
  • Degraded DNA with A260/A280 ratio below 1.7 or above 2.0
  • Sample received in a non-EDTA anticoagulant tube
  • FTA card not properly dried or contaminated
  • Sample collected more than 72 hours ago without refrigeration

Understanding Your Results

The results of the ITGB4 Gene Epidermolysis Bullosa Junctionalis with Pyloric Atresia NGS Genetic Test should be interpreted by a qualified clinical geneticist or genetic counsellor in the context of the patient's clinical presentation, family history, and histopathological findings. The presence of two pathogenic or likely pathogenic variants in the ITGB4 gene in trans configuration confirms the diagnosis of EB-PA. Carrier status is indicated when one pathogenic variant is identified. Variants of uncertain significance require additional family studies, functional data, or clinical correlation before they can be assigned clinical significance.
📊

Confirms diagnosis of ITGB4-related epidermolysis bullosa junctionalis with pyloric atresia. Genetic counselling and multidisciplinary management are recommended.

📊

Individual is a carrier of ITGB4-related EB-PA. May indicate the need for additional testing (e.g., deletion/duplication analysis) or testing of parents.

📊

Clinical significance cannot be determined at this time. Additional family studies, functional assays, and clinical correlation are recommended. Follow-up reassessment is advised.

📊

ITGB4-related EB-PA is unlikely based on this analysis. Consider testing for other genes associated with epidermolysis bullosa such as LAMB3, LAMC2, LAMA3, COL17A1, or PLEC. Clinical and histopathological reassessment is recommended.

⚠️ When to Consult a Doctor:

Consult your doctor or genetic counsellor if your child is born with widespread skin blistering, poor weight gain, feeding difficulties, or signs of gastrointestinal obstruction. If there is a family history of epidermolysis bullosa or pyloric atresia, seek genetic counselling before conception or during early pregnancy. If your test results identify a variant of uncertain significance, schedule a follow-up consultation to discuss implications and next steps.

Limitations

  • This test analyses only the ITGB4 gene; mutations in other genes associated with epidermolysis bullosa (e.g., LAMB3, LAMC2, LAMA3, COL17A1) are not covered
  • Deep intronic mutations and regulatory region variants may not be detected
  • Variants of uncertain significance (VUS) cannot definitively confirm or exclude disease
  • This test does not detect trinucleotide repeat expansions or balanced chromosomal rearrangements
  • Genotype-phenotype correlation may not always be straightforward

Risks & Considerations

  • Minor bruising or discomfort at the blood collection site
  • Emotional impact of genetic diagnosis on the patient and family
  • Identification of variants of uncertain significance may cause anxiety
  • Incidental carrier status findings relevant to family planning

Interfering Factors

  • Degraded or insufficient DNA quality may affect sequencing coverage
  • Recent blood transfusion within 4 weeks may affect results
  • Sample contamination during collection or transport
  • Mosaicism may not be fully detectable at standard sequencing depth

Compare With Similar Tests

TestITGB4 Gene Epidermolysis bullosa junctionalis with pyloric atresia NGS Genetic TestSkin Biopsy with Immunofluorescence MappingSanger Sequencing of ITGB4 GeneWhole Exome Sequencing (WES)Electron Microscopy of Skin Biopsy
ComparisonITGB4 Gene Epidermolysis bullosa junctionalis with pyloric atresia NGS Genetic Test

Frequently Asked Questions

What is the ITGB4 Gene Epidermolysis Bullosa Junctionalis with Pyloric Atresia NGS Genetic Test?
This is a next-generation sequencing (NGS) based genetic test that analyses the ITGB4 gene for mutations responsible for epidermolysis bullosa junctionalis with pyloric atresia (EB-PA), a rare disorder causing skin blistering and gastrointestinal obstruction at birth.
Who should get this ITGB4 Gene EB-PA NGS Genetic Test?
This test is recommended for newborns or infants with widespread skin blistering and suspected pyloric atresia, individuals with a clinical diagnosis of junctional epidermolysis bullosa, and family members seeking carrier testing or prenatal genetic counselling.
What sample is required for this test?
The test requires a blood sample (3-5 mL in an EDTA tube), extracted DNA, or a single drop of blood on an FTA card. No fasting is required for sample collection.
How long does it take to get the results?
Results are typically available within 3 to 4 weeks from the date the sample is received at the laboratory. Results can be accessed through the online portal, email, or WhatsApp.
What is the cost of the ITGB4 Gene EB-PA NGS Genetic Test?
The cost of the test is INR ?20000. This includes home sample collection, NGS sequencing, bioinformatic analysis, variant interpretation, a detailed clinical report, and raw data files (FASTQ and VCF).
Is home sample collection available for this test?
Yes, DNA Labs India offers free home sample collection for online bookings across India. This service is available in all major cities including Mumbai, Delhi, Bangalore, Hyderabad, Chennai, Kolkata, Pune, and many more.
What is epidermolysis bullosa junctionalis with pyloric atresia (EB-PA)?
EB-PA is a rare genetic disorder characterised by skin fragility with blistering from birth and pyloric atresia, which is a blockage of the lower part of the stomach. It is caused by mutations in the ITGB4 gene (or sometimes ITGA6) and can range from moderate to life-threatening.
How is EB-PA different from other types of epidermolysis bullosa?
EB-PA is a subtype of junctional epidermolysis bullosa specifically associated with pyloric atresia. Unlike EB simplex or dystrophic EB, EB-PA involves mutations in hemidesmosome proteins (integrin beta-4) and causes both skin and gastrointestinal complications, making it more severe.
What do the raw data files (FASTQ and VCF) include?
FASTQ files contain the raw sequencing reads generated by the NGS platform. VCF (Variant Call Format) files list all detected genetic variants with their positions, allele frequencies, and quality scores. These files allow independent bioinformatic analysis and second-opinion review by your healthcare provider.
Can this test be used for prenatal diagnosis?
Yes, if a familial ITGB4 mutation has been previously identified in the family, targeted prenatal testing can be performed on chorionic villus sampling (CVS) or amniocentesis samples. Genetic counselling is strongly recommended before prenatal testing.
What happens if a variant of uncertain significance (VUS) is found?
A VUS means the detected genetic change has insufficient evidence to be classified as pathogenic or benign at this time. Your genetic counsellor may recommend additional family studies, functional assays, or periodic reassessment as new research becomes available.
Does DNA Labs India share raw data and sequencing files with patients?
Yes, DNA Labs India is transparent and shares raw data, FASTQ files, and VCF files along with the conclusive clinical genetic report. This allows patients and their healthcare providers to review the data independently.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.